mRNA Cancer Vaccines and Therapeutics Market - Global Outlook and Forecast 2021-2027

Publisher Name :
Date: 09-Sep-2021
No. of pages: 93

This report contains market size and forecasts of mRNA Cancer Vaccines and Therapeutics in Global, including the following market information:

Global mRNA Cancer Vaccines and Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global mRNA Cancer Vaccines and Therapeutics market was valued at 117.7 million in 2020 and is projected to reach US$ 229.5 million by 2027, at a CAGR of 18.2% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the mRNA Cancer Vaccines and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global mRNA Cancer Vaccines and Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global mRNA Cancer Vaccines and Therapeutics Market Segment Percentages, By Type, 2020 (%)

- Adeno Carcinomas

- Mucinous Carcinomas

- Adenosquamous Carcinomas

China mRNA Cancer Vaccines and Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)

China mRNA Cancer Vaccines and Therapeutics Market Segment Percentages, By Application, 2020 (%)

- Infectious Disease

- Cancer

- Others

Global mRNA Cancer Vaccines and Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global mRNA Cancer Vaccines and Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total mRNA Cancer Vaccines and Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total mRNA Cancer Vaccines and Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

- Moderna Therapeutics

- CureVac

- Translate Bio

- BioNTech

- Sangamo Therapeutics

- Argos Therapeutics

- In-Cell-Art

- eTheRNA

- Ethris

- Tiba Biotechnology

mRNA Cancer Vaccines and Therapeutics Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 mRNA Cancer Vaccines and Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Cancer Vaccines and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Cancer Vaccines and Therapeutics Overall Market Size
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size: 2021 VS 2027
2.2 Global mRNA Cancer Vaccines and Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top mRNA Cancer Vaccines and Therapeutics Players in Global Market
3.2 Top Global mRNA Cancer Vaccines and Therapeutics Companies Ranked by Revenue
3.3 Global mRNA Cancer Vaccines and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 mRNA Cancer Vaccines and Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies mRNA Cancer Vaccines and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 mRNA Cancer Vaccines and Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 mRNA Cancer Vaccines and Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 mRNA Cancer Vaccines and Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global mRNA Cancer Vaccines and Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Adeno Carcinomas
4.1.3 Mucinous Carcinomas
4.1.4 Adenosquamous Carcinomas
4.2 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue & Forecasts
4.2.1 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global mRNA Cancer Vaccines and Therapeutics Market Size, 2021 & 2027
5.1.2 Infectious Disease
5.1.3 Cancer
5.1.4 Others
5.2 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue & Forecasts
5.2.1 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global mRNA Cancer Vaccines and Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue & Forecasts
6.2.1 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2027
6.3.2 US mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.3.3 Canada mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.3.4 Mexico mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2027
6.4.2 Germany mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.4.3 France mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.4.4 U.K. mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.4.5 Italy mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.4.6 Russia mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.4.8 Benelux mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2027
6.5.2 China mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.5.3 Japan mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.5.4 South Korea mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.5.6 India mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2027
6.6.2 Brazil mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.6.3 Argentina mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2027
6.7.2 Turkey mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.7.3 Israel mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.7.5 UAE mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Moderna Therapeutics
7.1.1 Moderna Therapeutics Corporate Summary
7.1.2 Moderna Therapeutics Business Overview
7.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.1.4 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
7.1.5 Moderna Therapeutics Key News
7.2 CureVac
7.2.1 CureVac Corporate Summary
7.2.2 CureVac Business Overview
7.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.2.4 CureVac mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
7.2.5 CureVac Key News
7.3 Translate Bio
7.3.1 Translate Bio Corporate Summary
7.3.2 Translate Bio Business Overview
7.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.3.4 Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
7.3.5 Translate Bio Key News
7.4 BioNTech
7.4.1 BioNTech Corporate Summary
7.4.2 BioNTech Business Overview
7.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.4.4 BioNTech mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
7.4.5 BioNTech Key News
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics Corporate Summary
7.5.2 Sangamo Therapeutics Business Overview
7.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.5.4 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
7.5.5 Sangamo Therapeutics Key News
7.6 Argos Therapeutics
7.6.1 Argos Therapeutics Corporate Summary
7.6.2 Argos Therapeutics Business Overview
7.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.6.4 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
7.6.5 Argos Therapeutics Key News
7.7 In-Cell-Art
7.7.1 In-Cell-Art Corporate Summary
7.7.2 In-Cell-Art Business Overview
7.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.4.4 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
7.7.5 In-Cell-Art Key News
7.8 eTheRNA
7.8.1 eTheRNA Corporate Summary
7.8.2 eTheRNA Business Overview
7.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.8.4 eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
7.8.5 eTheRNA Key News
7.9 Ethris
7.9.1 Ethris Corporate Summary
7.9.2 Ethris Business Overview
7.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.9.4 Ethris mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
7.9.5 Ethris Key News
7.10 Tiba Biotechnology
7.10.1 Tiba Biotechnology Corporate Summary
7.10.2 Tiba Biotechnology Business Overview
7.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.10.4 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
7.10.5 Tiba Biotechnology Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. mRNA Cancer Vaccines and Therapeutics Market Opportunities & Trends in Global Market
Table 2. mRNA Cancer Vaccines and Therapeutics Market Drivers in Global Market
Table 3. mRNA Cancer Vaccines and Therapeutics Market Restraints in Global Market
Table 4. Key Players of mRNA Cancer Vaccines and Therapeutics in Global Market
Table 5. Top mRNA Cancer Vaccines and Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global mRNA Cancer Vaccines and Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies mRNA Cancer Vaccines and Therapeutics Product Type
Table 9. List of Global Tier 1 mRNA Cancer Vaccines and Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 mRNA Cancer Vaccines and Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - mRNA Cancer Vaccines and Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - mRNA Cancer Vaccines and Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - mRNA Cancer Vaccines and Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - mRNA Cancer Vaccines and Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. Moderna Therapeutics Corporate Summary
Table 31. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 32. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. CureVac Corporate Summary
Table 34. CureVac mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 35. CureVac mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. Translate Bio Corporate Summary
Table 37. Translate Bio mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 38. Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. BioNTech Corporate Summary
Table 40. BioNTech mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 41. BioNTech mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. Sangamo Therapeutics Corporate Summary
Table 43. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 44. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. Argos Therapeutics Corporate Summary
Table 46. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 47. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. In-Cell-Art Corporate Summary
Table 49. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 50. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. eTheRNA Corporate Summary
Table 52. eTheRNA mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 53. eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. Ethris Corporate Summary
Table 55. Ethris mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 56. Ethris mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. Tiba Biotechnology Corporate Summary
Table 58. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 59. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. mRNA Cancer Vaccines and Therapeutics Segment by Type
Figure 2. mRNA Cancer Vaccines and Therapeutics Segment by Application
Figure 3. Global mRNA Cancer Vaccines and Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global mRNA Cancer Vaccines and Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2020
Figure 8. By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 12. US mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 24. China mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. CureVac mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. BioNTech mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Ethris mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs